Optimising treatment with tumour necrosis factor inhibitors in rheumatoid arthritis: is dose tapering practical in good responders? A 'proof of principle' and exploratory trial (OPTTIRA)

Project: Research

Project Details

Effective start/end date1/04/200930/09/2014

Collaborative partners

  • King's College London (lead)
  • MRC Clinical Trials Unit
  • National Rheumatoid Arthritis Society
  • Crescendo Bioscience


  • Arthritis Research UK: £436,823.00